RSS-Feed abonnieren

DOI: 10.1055/s-0045-1812050
Clinical and Endoscopic Features in Patients with Inflammatory Bowel Disease and Serrated Epithelial Change
Authors
Funding None.

Abstract
Background and Objectives
Serrated epithelial change (SEC) is an increasingly recognized histologic finding in patients with inflammatory bowel disease (IBD) and may be associated with an increased risk of colorectal dysplasia. SEC is defined as colonic mucosa with goblet cell–rich epithelium and serrated crypt architecture without basal crypt distortion or dysplasia. This study aimed to characterize the clinical, endoscopic, and histologic features of SEC in IBD patients and determine the incidence of associated dysplasia.
Materials and Methods
A retrospective single-center study was conducted at a tertiary referral hospital. IBD patients with histologically confirmed SEC from colonic biopsies between January 1, 2015 and December 31, 2024 were identified via pathology database searches. Patients without follow-up colonoscopy or flexible sigmoidoscopy were excluded. Clinical, endoscopic, and histologic data were extracted from electronic records. Descriptive statistics were used to summarize demographics, endoscopic findings, and histologic data. Median values were reported for age and follow-up time; mean values described disease duration.
Results
Twenty-six IBD patients (16 Crohn's disease, 10 ulcerative colitis) with SEC were analyzed (14 males; median age 58 years). Mean disease duration was 15 years, with a median follow-up of 24.5 months. The estimated prevalence of SEC was . A total of 30 SEC specimens were identified, most commonly located in the cecum (30%), rectum (23.3%), and transverse colon (16.7%). SEC presented as nodular or polypoid lesions in 60% of cases and was detected by high-definition white light endoscopy in 61.5% of patients. Multifocal SEC occurred in 19.2% of patients. Endoscopic and histologic inflammations were present in approximately half of the cases. Only one patient (3.8%) developed low-grade dysplasia adjacent to SEC.
Conclusion
SEC was predominantly observed in patients with long-standing IBD as polypoid or nodular lesions proximal to the splenic flexure and associated with mucosal inflammation. A solitary case of colorectal dysplasia was observed. Larger prospective studies are needed to clarify SEC's role in colorectal carcinogenesis and to guide dysplasia surveillance strategies in IBD.
Authors' Contributions
L.V.: Study design, methodology, data collection, formal analysis, original draft preparation, and final approval of the manuscript.
P.K.R.: Study design, methodology, formal analysis, review and editing, and final approval of the manuscript.
S.P.: Formal analysis, review and editing, and final approval of the manuscript.
T.W.: Formal analysis and final approval of the manuscript.
W.M.: Study design, methodology, formal analysis, data curation, review and editing, and final approval of the manuscript.
Ethical Approval
The Gold Coast Hospital and Health Service Human Research Ethics Committee has reviewed this study and granted ethical approval on 08/05/2024. HREC reference: HREC/2024/QGC/106193.
Publikationsverlauf
Artikel online veröffentlicht:
25. September 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn’s disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 1994; 35 (07) 950-954
- 2 Ekbom A. Increased risk of colorectal cancer in patients with ulcerative colitis. N Engl J Med 1990; 323 (15) 1020-1022
- 3 Jess T, Gamborg M, Matzen P, Munkholm P, Sørensen TI. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 2005; 100 (12) 2724-2729
- 4 Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 2012; 10 (06) 639-645
- 5 Johnson DH, Khanna S, Smyrk TC. et al. Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitis. Aliment Pharmacol Ther 2014; 39 (12) 1408-1417
- 6 Parian A, Koh J, Limketkai BN. et al. Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease. Gastrointest Endosc 2016; 84 (01) 87-95.e1
- 7 Parian AM, Limketkai BN, Chowdhury R. et al. Serrated epithelial change is associated with high rates of neoplasia in ulcerative colitis patients: a case-controlled study and systematic review with meta-analysis. Inflamm Bowel Dis 2021; 27 (09) 1475-1481
- 8 Bahceci D, Wang D, Lauwers GY, Choi WT. The development of serrated epithelial change in ulcerative colitis is not significantly associated with increased histologic inflammation. Am J Surg Pathol 2024; 48 (06) 719-725
- 9 Singhi AD, Waters KM, Makhoul EP. et al. Targeted next-generation sequencing supports serrated epithelial change as an early precursor to inflammatory bowel disease-associated colorectal neoplasia. Hum Pathol 2021; 112: 9-19
- 10 Farraye FA, Odze RD, Eaden J. et al; AGA Institute Medical Position Panel on Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010; 138 (02) 738-745
- 11 Laine L, Kaltenbach T, Barkun A, McQuaid KR, Subramanian V, Soetikno R. SCENIC Guideline Development Panel. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology 2015; 148 (03) 639-651.e28
- 12 Mohamed MFH, Marino D, Elfert K. et al. Dye chromoendoscopy outperforms high-definition white light endoscopy in dysplasia detection for patients with inflammatory bowel disease: an updated meta-analysis of randomized controlled trials. Am J Gastroenterol 2024; 119 (04) 719-726
- 13 Pohl J, Schneider A, Vogell H, Mayer G, Kaiser G, Ell C. Pancolonic chromoendoscopy with indigo carmine versus standard colonoscopy for detection of neoplastic lesions: a randomised two-centre trial. Gut 2011; 60 (04) 485-490
- 14 Manta R, Zullo A, Telesca DA. et al. Endoscopic submucosal dissection for visible dysplasia treatment in ulcerative colitis patients: case series and systematic review of literature. J Crohns Colitis 2021; 15 (01) 165-168
- 15 Lutgens MW, van Oijen MG, van der Heijden GJ, Vleggaar FP, Siersema PD, Oldenburg B. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis 2013; 19 (04) 789-799
- 16 Batts KP, Atwaibi M, Weinberg DI, McCabe RP. Significance of serrated epithelial change in inflammatory bowel disease. Postgrad Med 2021; 133 (01) 66-70
- 17 Kilgore SP, Sigel JE, Goldblum JR. Hyperplastic-like mucosal change in Crohn's disease: an unusual form of dysplasia?. Mod Pathol 2000; 13 (07) 797-801